Abstract
The licensed anthrax vaccine and many of the new anthrax vaccines being developed are based on protective antigen (PA), a nontoxic component of anthrax toxin. For this reason, an understanding of the immune response to PA vaccination is important. In this study, we examined the antibody response elicited by PA-based vaccines and identified the domains of PA that contribute to that response in humans as well as nonhuman primates (NHPs) and rabbits, animal species that will be used to generate efficacy data to support approval of new anthrax vaccines. To this end, we developed a competitive enzyme-linked immunosorbent assay (ELISA), using purified recombinant forms of intact PA and its individual domains. We found that PA-based vaccines elicited IgG antibodies to each of the four PA domains in all three species. We also developed a competitive toxin neutralization assay, which showed that rabbits, NHPs, and humans all have functional antibody populations that bind to domains 1, 3, and 4. While the domain specificities of the antibody responses elicited by PA-based vaccines were similar in humans, NHPs, and rabbits, competitive assays suggested that humans may have a more significant secondary population of IgG antibodies that bin...Continue Reading
References
Feb 14, 1992·Journal of Immunological Methods·C Schwab, H R Bosshard
Oct 14, 1970·Journal of Molecular Biology·M Mandel, A Higa
Jan 1, 1995·Infection and Immunity·V M GordonS H Leppla
Feb 3, 1993·Journal of Immunological Methods·P K NgaiH R Bosshard
Dec 1, 1995·Vaccine·B IvinsP Gibbs
Mar 1, 1996·Microbiology·Stephen F LittleArthur M Friedlander
Feb 27, 1997·Nature·C PetosaR C Liddington
Mar 7, 1998·Letters in Applied Microbiology·J MillerL W Baillie
Sep 4, 1999·Journal of Applied Microbiology·M L PittA M Friedlander
Sep 9, 1999·The New England Journal of Medicine·T C DixonP C Hanna
Apr 20, 2001·Vaccine·P F FellowsA M Friedlander
Dec 12, 2001·Vaccine·P R PittmanA M Friedlander
Feb 21, 2002·Infection and Immunity·Helen C Flick-SmithE Diane Williamson
Mar 16, 2002·Infection and Immunity·Helen C Flick-SmithE Diane Williamson
Sep 13, 2002·Current Topics in Microbiology and Immunology·A M FriedlanderB E Ivins
Oct 25, 2002·Emerging Infectious Diseases·Daniel B JerniganUNKNOWN National Anthrax Epidemiologic Investigation Team
Oct 23, 2003·Annual Review of Cell and Developmental Biology·R John Collier, John A T Young
Aug 25, 2004·Proceedings of the National Academy of Sciences of the United States of America·D Borden LacyR John Collier
Dec 14, 2004·Microbiology and Molecular Biology Reviews : MMBR·Andrew J PhippsMichael D Lairmore
Aug 23, 2005·Infection and Immunity·E D WilliamsonC P Quinn
Aug 16, 2006·Journal of Applied Microbiology·L W J Baillie
Aug 21, 2007·Molecular Immunology·Jianhui ZhouDonald C Reason
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John D Grabenstein
May 16, 2008·Clinical and Vaccine Immunology : CVI·Nareen Abboud, Arturo Casadevall
Jun 21, 2008·Vaccine·Donald C ReasonJianhui Zhou
Jun 28, 2008·Vaccine·Maryna EichelbergerDavid Wood
Nov 14, 2008·Development·Eric S VeienRichard I Dorsky
Feb 19, 2009·Infection and Immunity·Donald ReasonJianhui Zhou
Aug 7, 2009·Clinical and Vaccine Immunology : CVI·Anita VermaDrusilla L Burns
Citations
May 3, 2013·Clinical and Vaccine Immunology : CVI·Hang LuDavid Alleva
Jul 21, 2012·Clinical and Vaccine Immunology : CVI·Leslie WagnerDrusilla L Burns
Mar 24, 2012·Clinical and Vaccine Immunology : CVI·Miriam M NgundiDrusilla L Burns
Nov 28, 2015·Vaccine·Ryan C McComb, Mikhail Martchenko
Jul 2, 2016·Vaccine·Juan C Amador-MolinaJuan L Arciniega
May 16, 2020·Pathogens·Vladimir SavranskyJoshua Reece
Apr 30, 2020·ACS Chemical Biology·Zeyu LuBradley L Pentelute